“It’s not that I don’t trust vaccines, I just don’t think I need them”: Perspectives on COVID-19 vaccination

Abstract

In Quebec (Canada), the roll-out of the vaccination started slowly in December 2020 due to limited vaccine supply. While the first and second doses were well-accepted among adults and vaccine uptake was above 90%, in late 2021 and 2022, vaccine acceptance decreased for children vaccination and receipt of a 3rd or a 4th dose. In the autumn of 2022, four focus groups were conducted with vaccine-hesitant parents of children aged 0–4 and adults who expressed little intention to receive a booster dose. The objective of this study was to gather participants’ perspectives on vaccination in general, on the COVID-19 vaccination campaign and the information available, and to gain insights into the underlying reasons for their low intention of either having their child(ren) vaccinated, or receiving an additional dose of vaccine. A total of 35 participants took part in the focus groups. While participants expressed a certain level of trust and confidence in public health and government authorities regarding pandemic management and the vaccination campaign, they were also concerned that transparent information was lacking to support an informed decision on booster doses and children’s vaccination. Many participants felt adequately protected against the infection during the focus groups, citing a lack of perceived benefits as the primary reason for refusing a booster dose. Parents who refused to administer the COVID-19 vaccine to their young children felt that the vaccine was not useful for children and were concerned about potential side effects. The majority reported that their opinions regarding other recommended vaccines had not changed since the beginning of the pandemic. While these results are reassuring, our findings highlight the importance of transparency in public health communications about vaccines to increase confidence and to develop strategies to address vaccine fatigue and complacency toward COVID-19 vaccines.

Untitled

“…Todas las vacunas disponibles generan inmunogenicidad y son efectivas contra el SARS-CoV-2, además poseen pocos efectos adversos graves. A pesar de la actual evidencia sobre la eficacia de todas estas vacunas, muchos sujetos no (4,5) están seguros de recibirla Actualmente contamos con estudios que demuestran suficiente evidencia en la reducción de las hospitalizaciones por COVID-19, diminución en la severidad de las manifestaciones clínicas de la (6). enfermedad y en el número de muertes por COVID-19 atribuibles a la inmunización En el Paraguay, las vacunas estuvieron disponibles el 22 febrero 2021.…”